This molecule is well known for its action against melanin. Applying the principle of Similia and Hormesis, its clinical usefulness has been observed by the inventor in the treatment of vitiligo. Vitiligo affects about 2% of the world and 8% of Indian population. Hydroquinone in ultra-dilute and potentized form has demonstrated stimulation of melanin pigment, probably by activating the process of melanogenesis. In the clinical practice, the inventor has used this medicine in a large number of patients with good benefits. Human study has shown safety in a study. A human study was conducted to see effects of Hydroquinone on humans.
Hydroquinone is better indicated in segmental and mild forms of vitiligo; and not in the bilateral symmetrical variety or large patches. It may help control the disease process as well as show pigmentation in some cases.
A recent study at eminent conventional government medical college and hospital, BYL Nair Hospital in Mumbai, at the department of Clinical Pharmacology has demonstrated the anti-vitiligo efficacy of Hydroquinone in cell line model. The study was initiated by Dr Rajesh Shah.
- Hypo pigmentation in leucoderma, pityriasis versicolor, scleroderma, etc.
- “Hydroquinone: Homoeopathy pathogenetic trial” in Indian Journal of Research in Homoeopathy; Vol. 7 (2): Apr-Jun 2013. http://www.ijrh.org/article.asp?issn=0974-7168;year=2013;volume=7;issue=2;spage=47;epage=61;aulast=Shah
- “Evaluation of Melanogenic and anti-Vitiligo activities of homeopathic preparations on Murine B16F10 Melanoma cells”, http://www.ejpmr.com/home/abstract_id/2659
- “Homeopathy may treat Malaria, Vitiligo: Research”, Business Standard 31 July 2017, http://www.business-standard.com/article/news-ians/homoeopathy-may-treat-malaria-vitiligo-patients-research-117073101039_1.html